Skip to main
GEHC

GEHC Stock Forecast & Price Target

GEHC Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 18%
Buy 29%
Hold 53%
Sell 0%
Strong Sell 0%

Bulls say

GE HealthCare Techs is expected to continue to see growth through their focus on recurring revenue through services and digital solutions, as well as their investment in new products and expansion into underserved markets. They also have a strong position in the market through the integration of their Advanced Visualization Solutions and Imaging segments and are investing in AI and software solutions, showcasing their commitment to innovation. However, potential challenges in the China market and underperformance in the Patient Care Solutions division may impact their growth in the short term. Overall, GE HealthCare Techs is a solid company with a positive outlook for the future.

Bears say

GE HealthCare Techs is a diversified medical technology company with a global presence and a strong focus on innovation and growth. Despite competition and potential risks such as economic challenges and changes in pricing proposals, their solid financials and expected clearance for a new product in the near future are likely to support their Buy rating. However, their reliance on recurring revenue and recurring service contracts raises concerns about the sustainability of their growth in the long term.

GEHC has been analyzed by 17 analysts, with a consensus rating of Buy. 18% of analysts recommend a Strong Buy, 29% recommend Buy, 53% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GE HealthCare Technologies Inc (GEHC) Forecast

Analysts have given GEHC a Buy based on their latest research and market trends.

According to 17 analysts, GEHC has a Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GE HealthCare Technologies Inc (GEHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.